Hepatitis C E1 and E2 polypeptides and methods of obtaining the same
US6121020A · kind A · utility
14Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 24, 1997 |
| Grant date | Sep 19, 2000 |
| Priority date | — |
| Expiry date | Mar 24, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/24222
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel Hepatitis C E1 and E2 truncated polypeptides and complexes comprising these polypeptides, are disclosed. The polypeptides are C-terminally truncated to remove all or a portion of their membrane spanning domains. Hence, the polypeptides are capable of secretion when expressed recombinantly.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.